Get informed when a big investor buys or sells
+ FollowOvervalued by 110.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $35.78 Million |
|---|---|
| Enterprise Value | $40.00 Million |
| Earnings per Share | $-0.04 |
| Beta | 0.34 |
| Outstanding Shares | 132,296,720 |
| P/E Ratio | -6.27 |
|---|---|
| PEG | 10.52 |
| Price to Sales | - |
| Price to Book Ratio | -0.26 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.78 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -0.98 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Specializing in research and product development, Ocumetics Technology Corp. engineers and manufactures a range of optical lenses. A flagship offering is the Bionic Lens, an innovative, expandable intraocular lens designed to be precisel...